Key facts
- It has raised $310K across 1 recorded rounds; the latest was Seed Round ($264K) in Sep 2024.
- Airobes has filed 3 Form Ds with the SEC since 2024, most recently Sep 2025 ($50K sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Airobes
Funding rounds
1 roundsAbout Airobes
Developer of biotechnology systems designed to capture carbon and convert it into valuable biomaterials. The company offers a two-organism platform that produces recombinant proteins directly from CO₂, enabling industrial biotech and manufacturing sectors to overcome scalability limitations and reduce production costs.
- Sector
- Business Products and Services (B2B)
- HQ
- Phoenix, AZ, United States
- Founded
- 2024
- Employees
- 4
- Website
- airobes.com/
- Ownership
- Privately Held (backing)
Airobes doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Airobes shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Airobes in its N-PORT filings yet. We sweep new filings monthly.